Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents

NCT02118961 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

446

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Tetanus
Pertussis

Interventions

BIOLOGICAL: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP vaccine, BK1301)
BIOLOGICAL: Adsorbed Diphtheria-Tetanus Combined Toxoid (DT toxoid)

Sponsor

Tanabe Pharma Corporation

Collaborators

[object Object]